This PPT is for the all the nursing staff and student working at clinical sided to control infection, maintain aseptic technique while doing procedure and compulsory use the PPE.
This PPT is for the all the nursing staff and student working at clinical sided to control infection, maintain aseptic technique while doing procedure and compulsory use the PPE.
Role of nurses in infection control dr.rs 07 04-2016SOMESHWARAN R
Role of nurses in infection control Universal safety precautions Hand washing Needle stick injury Post exposure prophylaxis MBBS UG STUDENTS MEDICINE CLASS THEORY PPT Power point
Prevention of Accidents in An Operation Theatre Part 2-NURSINGMariaKuriakose5
This contains a detailed information about what causes accidents in an operation theater,its preventive measures and what else to be done to prevent such hazards taking place in an OT
updated guidelines of hospital infection control, as mentioned in the ppt. its not all the guidelines but yes a brief overview and for further details refer to hospital infection control guidelines pdf.which is available in my uploads.
Role of nurses in infection control dr.rs 07 04-2016SOMESHWARAN R
Role of nurses in infection control Universal safety precautions Hand washing Needle stick injury Post exposure prophylaxis MBBS UG STUDENTS MEDICINE CLASS THEORY PPT Power point
Prevention of Accidents in An Operation Theatre Part 2-NURSINGMariaKuriakose5
This contains a detailed information about what causes accidents in an operation theater,its preventive measures and what else to be done to prevent such hazards taking place in an OT
updated guidelines of hospital infection control, as mentioned in the ppt. its not all the guidelines but yes a brief overview and for further details refer to hospital infection control guidelines pdf.which is available in my uploads.
Dr. Prince is an experienced Microbiology teacher with 24 years of experience in teaching various medical and paramedical students.
This ppt explains the types of hospital acquired infection and their control methods.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Hospital Infection Control Guidelines-LECTURE (4).pptx
1. Modified from Dr. Walied K Balwan’s
Presentation Department of Community
Medicine SKIMS
HOSPITAL INFECTION CONTROL
GUIDELINESS
2. Nosocomial infections / hospital-acquired
infections / hospital-associated infections /
hospital infections.
They are a serious health hazard. Lead to increased patients’
Morbidity and mortality,
length of hospital stay
the costs associated with hospital stay.
3. Common healthcare associated infections
Catheter associated urinary tract
infection (CAUTI)
Surgical site Infection (SSI)
Catheter related blood stream infection
(CRBSI)
Ventilator Associated Pneumonia (VAP)
4. Direct contact
between healthy and unhealthy
person
Airborne
Viruses and bacteria spread
through coughing and sneezing
Ingestion
Usually through water and food
Insect
or
animal bite
The routes
of
Transmission
How infections are transmitted
5. Sources of microorganisms
Surfaces
Hands,
Devices
Water, Food
Blood
Pharmaceutical agents
Patients at risk
Frequent hospital
admissions IVDUs,
Immunocompromised
Acute wounds
Using equipments internal to
patients
e.g. Catheters
Transmission of pathogens
between staff, patients and among
patients
Patients at risk for BBIs
Sharing infected
equipment. Contaminated
skin puncture.
From mother to child.
Contamination of wounds.
Blood transfusion.
HAI
What leads to HAI
7. Is central to providing high quality health care for patients and a safe working
environment for those that work in healthcare settings.
It is important to minimize the risk of spread of infection to patients and staff in
hospital by
implementing good infection control programme.
9. HOSPITAL INFECTION
CONTROL
PROGRAM
• Prevention of HCAI in patients is a
concern of everyone in the facility and
is the responsibility of all individuals
and services providing health care.
• Risk prevention for patients and staff
must be supported at the level of
senior administration.
10. Components of infection
control
programme
1. Basic measure for infection control-standard
and additional precaution
2. Education and training of health care
workers.
3. Protection of health care workers
4. Identification of hazards and minimizing
risks.
5. Aseptic techniques
6. Use of single use device,
reproccessing of instrumental and
11. 7. Antibiotic usage,management of
body/blood fluid,exposure handling of
blood/blood product and hospital waste
management.
8. Surveillance
9. Outbreak investigation
10.Incident monitoring
12. OBJECTI
VES
• The main objectives of these guidelines is to
prevent the health care workers and the
environment from the transmission of
infections:
• Facilities, equipment, and procedures
necessary to implement standard
precautions.
• Cleaning, disinfecting and
reprocessing of reusable equipment.
• Waste management ,Prevention of
HAI in patients
13. Universal precautions
• Universal precautions are the set of guidelines
designed to protect the health care worker from
exposure to infections such as HIV< Hepatitis
B and C which are transmitted by blood and
certain body fluids of patient.
COMPONENTS; Universal precautions consider
only certain body fluids as capable of
transmitting blood borne disease
14. Precaution relatedto body
fluids
• Universal precaution
apply to:
• Blood
• Semen
• Vaginal secretions
• CSF
• Pleural/peritoneal/pericar
d ial/amniotic fluids
• Universal precaution
does not apply:
1. Feaces
2. Nasal secretions
3. Sputum
4. Sweat
5. Tears/urine/vomitus
6. saliva
15. The role of the hospital infection control committee
(HICC) is to implement the annual infection control
Programme and policies.
1. Commitment towards Maintenance of
Surveillance over HCAIs.
2. Develop a system for identifying,
reporting, analyzing, investigating and
controlling HCAIs.
3. Develop and implement preventive and
corrective programs in specific situations
where infection hazards exist.
16. 4. Advice the Medical Superintendent on
matters related to the proper use of
antibiotics, develop antibiotic policies and
recommend remedial measures when
antibiotic resistant strains are detected.
5. Review and update hospital infection
control policies and procedures from
time to time.
6. Help to provide employee health
education regarding matters related to
HCAIs.
7. HICC shall meet regularly - once a month
and as often as required
17. HospitalInfectionControlCommittee(HICC)
Is responsible
for establishing and maintaining infection prevention
and control,
its monitoring, surveillance,
reporting, research and education
The Committee is an integral component
of the
patient safety programme of the health care
facility
18. StructureofHospitalinfectioncontrolcommittee
Chairperson: Hospital administrator
Member Secretary: SeniorMicrobiologist
Members: Representation from
Management/Administration (Dean/Director
of Hospital; Nursing Services; Medical
Services; Operations)
Relevant Medical Faculties
Support Services: (OT/CSSD, House-
keeping/Sanitation, Engineering,
Pharmacologist, Store Officer / Materials
Department)
Infection Control Nurse (s)
Infection Control officer
19. Infection Control
Team
• The Infection control team should comprise
of at minimum
1. an infection control officer,
2. a microbiologist (if ICO is not a
microbiologist),
3. and infection control nurse.
ICT takes daily measures for the prevention
and control of infection in hospital.
20. ResponsibilitiesoftheTeam
Develop a
manual of
policies and
procedures for
aseptic, isolation
and antiseptic
techniques.
Carry out
targeted
surveillance of
HAIs, data
analysis and
take corrective
steps
Advise staff on
all aspects of
infection control
and maintain a
safe
environment for
patients and
staff.
Supervise and
monitor
cleanliness and
hygienic
practices
22. Responsibilitiesofthe hict
Training of all new
employees as to
the importance of
infection control
and the relevant
policies and
procedures.
Regular training
programme for
the staff to
ensure
implementation
of infection
control practices
Audit infection
control
procedures
and
antimicrobial
usage
Monitor
Health care
workers
safety
Programme.
23. I
N
F
E
C
T
I
O
NC
O
N
T
R
O
L
P
R
O
C
E
S
S
E
S
Standard Precautions
• Standard Precautions are designed to reduce the risk
of transmission of micro-organisms from both
recognized and unrecognized sources of infection in
the hospital. Standard Precautions applies to all
patients regardless of their diagnosis. Standard
Precautions shall be implemented when contact with
any of the following are anticipated:
1. Blood
2. All body fluids, secretions and excretions, with the
exception of sweat regardless of whether or not they
contain visible blood.
3. Non-intact skin (this includes rashes)
4. Mucous membranes
24. StandardPrecautionsRequirements
• A. Hand hygiene:
• Pathogenic organisms from colonized and infected
patients (and sometimes from the environment)
transiently contaminate the hands of staff during
normal clinical activities and can then be
transferred to other patients.
• Proper hand hygiene is an effective method for
preventing the transfer of microbes between staff
and patients. Increasing hand-washing
compliance by 1.5 – 2 folds would result in a 25-
50-% decrease in the incidence of healthcare
associated infections.
25. Five(5)MomentsinHandHygiene-
Hand hygiene must be practiced :
1. Before touching a patient.
2. Immediately before performing a clean or aseptic
procedure, including handling an invasive device for
patient care, regardless of whether or not gloves are
used.
3. Promptly after contact with body fluids, excretions,
mucous membranes, non-intact skin, or wound
dressings regardless of whether or not gloves were
used.
4. After touching a patient and his/her immediate
surroundings, even when leaving the patient’s side.
5. After contact with inanimate objects (including medical
equipment and furniture) in the immediate vicinity of the
patient.
26.
27. Handhygiene
Positiv
es
• Use
between
patients.
• Quick, easy
& effective.
• Can use when
going in and out
of wards, houses
or rooms.
• Use after gloves
kills 99.8% of
bacteria.
Negative
• Don’t work to kill
diarrhoea
viruses.
• Only use if
hands look
clean.
• If in doubt use
soap and water.
Alcohol gels 20-30
sec
Hand washing 40-60
sec
28. Personal protective
equipment-
1. Use of Gloves: Clean gloves must be worn
when touching blood, body fluids, excretions,
secretions and contaminated items and when
performing venipuncture.
2. Face Mask, eye protection & face shield:
Face Mask must be worn during procedures
or patient care activities that are expected to
generate splashes or sprays of blood, body
fluids.
29. N95
Respirators-
• Respirators are masks specifically designed
to filter small particles spread by the airborne
route, such as tuberculosis, measles and
varicella. They are used for aerosol
generating procedures that have been shown
to expose staff, including:
• Sputum induction
• Diagnostic bronchoscopy
• Autopsy examination
• Laboratory handling of Mycobacterium
tuberculosis such as concentrating
respiratory samples for smear and
culture.
31. Gown or Apron
• Gown/apron
protect
soiling
must be worn to
skin and to
of clothing
prevent
during
procedures or patient care
that
activities
generate splashes or sprays
are expected to
of
blood, body fluid, secretions and
excretions.
32. • Instruct symptomatic persons and health
care workers to cover their mouths/noses
when coughing or sneezing, use and
dispose of tissues, perform hand hygiene
after hands have been in contact with
respiratory secretions and wear surgical
mask if tolerated or maintain spatial
separation, >3 feet if possible.
33. • Respiratory hygiene/cough etiquette:
Instruct symptomatic persons and health
care workers to cover their mouths/noses
when coughing or sneezing, use and
dispose of tissues, perform hand hygiene
after hands have been in contact with
respiratory secretions and wear surgical
mask if tolerated or maintain spatial
separation, >3 feet if possible.
35. CLEANING
CLEANING OF ENVIRONMENTAL SURFACES
Clean housekeeping surfaces (e.g., floors, walls, tabletops) on a regular basis, when spills
occur, and
when these surfaces are visibly soiled.
Disinfect environmental surfaces (e.g., bedside tables, bedrails, and laboratory surfaces)
Clean walls, blinds, and window curtains.
Decontaminate mops heads and cleaning cloths regularly to prevent contamination (e.g.,
launder and
dry at least daily).
CLEANING OF BEDDING AND BLANKET
o Clean and disinfect mattress impermeable covers.
o Launder pillow covers, washable pillows, and blankets between patients or when they
become
contaminated with body substances.
36. DISINFECTION
DISINFECTION. Most microbes are removed from defined object or
surface, except spores.
Classified according to their ability to destroy different
categories of microorganisms:
• High Level disinfectants :
Glutaraldehyde 2%, Ethylene
Oxide
• Intermediate Level disinfectant
:
Alcohols, chlorine compounds,
hydrogen peroxide,
chlorhexidine,
• Low level disinfectants :
Benzalkonium chloride, some
soaps
37. General Guidelines for Disinfection
• Critical instruments/equipment (that
are
thos
e penetrating skinor mucous
membrane) should
undergo sterilization before and after use. e.g.
surgical instruments.
• Semi-critical instruments /equipments (that are
those in contact with intact mucous membrane
without penetration) should undergo high level
disinfection before use and intermediate level
disinfection after use. e.g. endotracheal tubes.
• Non-critical instruments /equipments (that are
those in contact with intact skin and no contact
with mucous membrane) require only intermediate
or low level disinfection before and after use. e.g.
38.
39. ISOLATION
PRECAUTIONS
Isolation precautions are needed to prevent
the transmission of pathogenic
microorganisms within the healthcare setting.
The patients of following disease categories
should be treated under isolation.
Severe influenza cases, Subacute respiratory
Syndrome (SARS), Open case of
tuberculosis, Anthrax, diphtheria, Pertussis,
Pneumonic plague, Chicken pox, and
patients infected with multidrug resistant
bacterial pathogens.
40. ISOLATIONPRECAUTIONS
Contact
precaution
s
Airborne
precaution
s:
Droplet
precaution
s
Enteric infections, diarrhea
that cannot be controlled, or
skin lesions that cannot be
contained.
Pathogens transmitted
by respiratory droplets
generated by a patient
by coughing, sneezing,
or talking,
Acute respiratory infection,
undiagnosed or meningitis
and/or sepsis with petechial
rash .
Infectious agents
transmitted person-
to- person by the
airborne route, such
as M. tuberculosis,
measles,
chickenpox,
disseminated herpes
zoster.
41.
42. Patient
placement
• Appropriate patient placement is a significant
component of isolation precautions.
Determine patient placement based on the
following principles:
• Route(s) of transmission of the infectious agent
• Risk factors for transmission in the infected patient
• Risk factors for adverse outcomes resulting from
healthcare- associated infection in other patients in the
area.
• Availability of single-patient rooms
• Patient options for room-sharing
43. Contact
Precautions:
1. Required for patients with enteric
infections, diarrhea that cannot be
controlled, or skin lesions that cannot be
contained.
44. Droplet
precaution
s:
Required for patients known or Suspected
to be infected with pathogens transmitted
by respiratory droplets that are generated
by a patient who is coughing,
sneezing, or talking,
Acute respiratory infection,
undiagnosed or meningitis and/or
sepsis with petechial rash .
45. 2.
Patient
placemen
t:
a. Place patients
who require
Contact
Precautions in a
single-patient
room when
available; if
single-patient
rooms are
unavailable, then
place patients
infected with the
same pathogen in
the same room.
b. If it becomes
necessary to place
a patient who
requires Contact
Precautions
in a room with a
patient who is not
infected or
colonized with the
same infectious
agent
46. i. Avoid placing
patients on
Contact
Precautions in the
same room with
patients who have
conditions that
may increase the
risk of adverse
outcome from
infection or that
may facilitate
transmission.
ii. Ensure
that
patients are
physically
separated
(i.e., >3 feet
apart) from
each other.
Draw the privacy
curtain between
beds to minimize
opportunities for
direct contact.
iii. Change
protective attire
and
perform hand
hygiene between
contacts with
patients in the
same room,
regardless of
whether one or
both patients are
on Contact
Precautions
47. • 3. Use of personal protective equipment:
• Don a mask upon entry into the patient
room or cubicle.
4. Patient transport
a.Limit transport and movement of patients
outside of the room to medically-necessary
purposes.
b. When transport or movement in any healthcare
setting is necessary, ensure that infected or
colonized areas of the patient’s body are
contained and covered.
c.Remove and dispose of contaminated PPE and
48. Airborne
precautions:
1. Required for patients
known or suspected to be
infected with infectious
agents transmitted
person-to-person by the
airborne route, such as
M. tuberculosis,
measles, chickenpox,
disseminated
herpes zoster.
2. Develop systems (e.g.,
triage, signage) to identify
patients with known or
suspected
infections that requires
Airborne Precautions
upon entry into the health
facility.
49. Patient
placement
a. Place
patients
who
require
Airborne
Precautions
in an
airborne
infection
isolation
room (AIIR)
that has
been
constructed
with the
following
conditions
i.
Provide
s 6-12
air
changes
per
hour.
ii. Directs
exhaust or
air to the
outside,
or through
HEPA filters
if
exhausting
to the
outside is
not
possible.
iii. Has a
monitor for
air
pressure
with visual
indicators.
iv. Can be
closed with
a door
when not
required for
entry and
exit.
50. b. If an AIIR is not available and transfer to
a facility with AIIR is not possible, place a
surgical mask on the patient and place
him/her in a single room. Once the patient
leaves, the room should remain vacant for
the appropriate time, generally
one hour, to allow for a full exchange of air.
c. Instruct patients with a known or
suspected airborne infection to wear a
surgical mask and
observe Respiratory Hygiene/Cough Etiquette.
Once
in AIIR, the mask may be removed
51. 4. Personnel
restrictions
a. Restrict susceptible healthcare personnel
from entering the rooms of patients known or
suspected to have measles, varicella, disseminated
zoster, or smallpox
if other immune healthcare personnel are
available.
52. 5. Use of personal protective
equipment
a.Healthcare personnel should use a
fit- tested respiratory, such as an N95,
before entering the room of a patient
with known
or suspected tuberculosis or
smallpox.
b. A fit-tested N95 or surgical mask may
be
appropriate for healthcare personnel to
wear while caring for patients with known
or suspected measles, chickenpox, or
disseminated herpes zoster.
53. 6.
Patient
transpo
rt
a. Limit
transpor
t
and
movement
of patients
outside of
the room
to
medically-
necessary
purposes.
b. If
transport or
movement
outside an
AIIR is
necessary,
instruct
patients to
wear a
surgical
mask, if
possible,
and observe
Respiratory
Hygiene/Cou
g h
Etiquette.
c. For
patients with
skin lesions
associated
with
varicella or
smallpox or
draining skin
lesions caused
by M.
tuberculosis,
cover the
affected areas
to prevent
aerosolization
or contact with
the infectious
agent in skin
lesions.
d.
Healthcare
personnel
transporting
patients who
are
on Airborne
Precautions do
not need to
wear a mask or
respirator
during
transport if the
patient is
wearing a
mask and
infectious skin
lesions are
covered.
54. 7.
Exposure
manageme
nt
a. Administer measles vaccine to exposed
susceptible persons within 72 h after the
exposure or administer
immune globulin within six days of the
exposure
event for high-risk persons in whom
vaccine is contraindicated.
b. Administer varicella vaccine to exposed
susceptible persons within 120 h after the
exposure or administer varicella immune
globulin, when available, within 96 h for high-
risk persons in whom vaccine is
contraindicated (e.g., immunocompromised
patients, pregnant women, newborns whose
mother’s varicella onset was <5 d before or
within 48 h after delivery).
c. Administer smallpox vaccine
to exposed susceptible
persons within 4 days after
exposure